Adaptive Biotechnologies appoints Tycho Peterson as CFO

Adaptive Biotechnologies Corp

Appointed Tycho Peterson as CFO effective on or before June 4, 2022; will serve as principal financial officer.
Annual salary of $425,000, plus annual incentive opportunity of 50% of salary, prorated for 2022.
Equity grants: 374,688 RSUs (4-yr vest) and 597,157 stock options (4-yr vest).
Previously Managing Director at J.P. Morgan; holds MBA from Oxford and BA from Cornell.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tycho Peterson

Chief Financial Officer

ADPT · Adaptive Biotechnologies Corp

Effective: 2022-06-04
Filed: March 11, 2022, 6:59 PM ET

On March 9, 2022, the Board of Directors of Adaptive Biotechnologies Corporation (the “ Company ”) appointed Tycho Peterson as Chief Financial Officer of the Company, effective upon his start date, no later than June 4, 2022 (the “ Effective Date ”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Tycho Peterson was appointed as Chief Financial Officer at Adaptive Biotechnologies Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 9, 2022, the Board of Directors of Adaptive Biotechnologies Corporation (the “ Company ”) appointed Tycho Peterson as Chief Financial Officer of the Company, effective upon his start date, no later than June 4, 2022 (the “ Effective Date ”).

View on SEC.gov

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR

accession 0001564590-22-009876

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.